Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether homeopathic injections administered by parenteral route were homeopathic medicines eligible for exemption under Tariff Item 14E of the Central Excise Tariff; (ii) Whether the demand could be defeated on the ground of estoppel against the authorities.
Issue (i): Whether homeopathic injections administered by parenteral route were homeopathic medicines eligible for exemption under Tariff Item 14E of the Central Excise Tariff
Analysis: Sections 16 and 18 of the Drugs and Cosmetics Act, 1940, read with the Second Schedule, permit manufacture only of drugs conforming to the prescribed standards. Homeopathic medicines were brought within the Schedule, but the appellant failed to establish that the injections manufactured and cleared by it were in accordance with the standards specified in the relevant homeopathic pharmacopoeias. Rule 2(dd) of the Drugs and Cosmetics Rules, 1945 clarified the position already implicit in the Act by excluding medicines administered by parenteral route from the definition of homeopathic medicines. The prior finding that such injections were not included in the relevant pharmacopoeias had become final.
Conclusion: The injections were not entitled to exemption under Tariff Item 14E, and duty was payable from 19 March 1966 onwards.
Issue (ii): Whether the demand could be defeated on the ground of estoppel against the authorities
Analysis: A demand raised under a taxing statute cannot be barred merely because the department had earlier permitted clearance of the goods; the doctrine of estoppel cannot override the statute.
Conclusion: The plea of estoppel failed.
Final Conclusion: The appeal succeeded only to the limited extent that the duty demand was confined to the period when the statutory control over homeopathic medicines had come into force, while the challenge to liability on merits and on estoppel failed.
Ratio Decidendi: Where a claimant fails to prove that the goods satisfy the statutory standards for homeopathic medicines, and the relevant rules exclude parenteral administration from that category, exemption under the tariff cannot be claimed; estoppel cannot defeat a statutory levy.